LATEST VERSION
DEVELOPING · 17 OCT → 24 OCT 2026 · 8 EDITIONS · 23 OUTLETS

India caps trade margins on 137 cancer drugs, with revised prices due November 9

How this story moved: how many newsrooms carried it at each run, when each one picked it up, how our summary's headline changed, and which figures and names held from the first reports to the latest. Everything here is counted from the coverage; none of it is a judgement of anyone's motives.

OUTLETS CARRYING THE STORY, RUN BY RUN

0 11 23 18 Oct 19 Oct 20 Oct 21 Oct 22 Oct 23 Oct 24 Oct 18 Oct 00:17 UTC · India caps trade margins on 137 anti-cancer drugs at 30% 18 Oct 18:17 UTC · India caps trade margins on 137 cancer drugs, with revised prices due November 9

HOW OUR HEADLINE CHANGED · 2 HEADLINES

  1. 18 Oct, 00:17 UTC

    India caps trade margins on 137 anti-cancer drugs at 30%

  2. 18 Oct, 18:17 UTC

    India caps trade margins on 137 cancer drugs, with revised prices due November 9

WHAT HELD, WHAT CAME LATER

From the first reports to the latest

  • 137 anti-cancer drugs · 9 outlets
  • 137 cancer drugs · 4 outlets

Entered the story later

  • Nothing new took hold after the first third.

Figures reported with different numbers

  • anti-cancer drugs: 137 (9 from 17 Oct 16:15) → 42 (1 from 17 Oct 17:36)
  • cancer medicines: 137 (2 from 17 Oct 23:49) → 42 (1 from 17 Oct 23:49)

Matched by pattern, not read: a different number can be a correction, a rising count, or two different counts.